The BNMS is seeking members to form a working party in molecular radiotherapy (MRT). The field is expanding rapidly with the introduction of new radiotherapeutics and legislation.
The group will be expected to address a number of issues including, but not limited to:
Drafting of a position statement in response to the new Basic Safety Standards (Euratom 2013/59)
Investigation of models of service delivery to ensure equality of access to innovative treatments
Promotion of research and development, including support for clinical trials
Engagement with similar bodies, including CTRad, iDUG, IPEM, UKRG.
If you would like to express an interest in this working group, or have any questions, please contact the BNMS at:email@example.com